Brief: Guardion Health Sciences Says Received An Initial Purchase From Astramune SDN BHD For A Sample Order Of Its Proprietary Immuno-Supportive Formula
April 1 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES INC - RECEIVED AN INITIAL
PURCHASE FROM
ASTRAMUNE SDN BHD FOR A SAMPLE ORDER OF ITS PROPRIETARY
IMMUNO-SUPPORTIVE FORMULA
Source: https://bit.ly/3aAqcul
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview